Ovarian Cancer
Studies from Jichi Medical University Have Provided New Data on Ovarian Cancer
Published in Women's Health Weekly, April 12th, 2012
2012 APR 12 -- Researchers detail in "Cetuximab inhibits the growth of mucinous ovarian carcinoma tumor cells lacking KRAS gene mutations," new data in Ovarian Cancer. "The purpose of this study was to explore the possibility of targeted molecular therapy with anti-epidermal growth factor receptor (anti-EGFR) antibody (cetuximab) for the treatment of mucinous ovarian carcinoma. We analyzed EGFR protein expression and KRAS gene mutations in 5 mucinous ovarian carcinoma cell lines RMUG-L, RMUG-S, MN-1, OMC-1 and MCAS and evaluated the in vitro and in vivo effects of cetuximab on each," investigators in Tochigi, Japan report.
"EGFR expression was...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Central Nervous System Depressants
Updated policy about consent for pelvic exams in Canada needs revision - Obstetrics and Gynecology
University of Milan Reports Research in Obstetrics and Gynecology - Teva Pharmaceutical Industries Ltd.
Teva Announces Launch of Authorized Generic of Provigil(R) - Asthma
Taking oral glucocorticoids for 3 months or longer? Beware of osteoporosis! - Peritoneal Dialysis
Study Results from University of Tokyo Update Understanding of Peritoneal Dialysis - Pregnancy
Study Results from University of Toronto in the Area of Pregnancy Published - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
